326437440	326437440	CD	B-NP	O
|	|	NN	I-NP	O
FSH	FSH	NN	I-NP	O
|	|	NN	I-NP	O
11135516	11135516	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
780579	780579	CD	B-NP	O
|	|	CC	I-NP	O
8/8/1999	8/8/1999	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CHOLECYSTITIS	CHOLECYSTITIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/20/1999	8/20/1999	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/9/1999	10/9/1999	CD	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CHOLOLITHIASIS	CHOLOLITHIASIS	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
2	2	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
CORONARY	CORONARY	NN	I-NP	O
ARTERY	ARTERY	NN	I-NP	O
DISEASE	DISEASE	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Cocker	Cocker	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
68-year-old	68-year-old	JJ	I-NP	O
Spanish	Spanish	JJ	I-NP	O
speaking	speaking	NN	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
known	known	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
health	health	NN	B-NP	O
until	until	IN	B-PP	O
August	August	NNP	B-NP	O
,	,	,	O	O
1999	1999	CD	B-NP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
developed	developed	VB	I-VP	O
right	right	JJ	B-NP	B-protein
upper	upper	JJ	I-NP	I-protein
quadrant	quadrant	JJ	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
and	and	CC	O	O
sent	send	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
possible	possible	JJ	B-NP	O
early	early	JJ	I-NP	O
acute	acute	JJ	I-NP	O
cholecystitis	cholecystitis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Surgical	Surgical	NNP	I-NP	O
Service	Service	NNP	I-NP	O
at	at	IN	B-PP	O
Xole	Xole	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
,	,	,	O	O
but	but	CC	O	O
managed	manage	VBD	B-VP	O
medically	medically	RB	B-ADVP	O
without	without	IN	B-PP	O
a	a	DT	B-NP	O
operative	operative	JJ	I-NP	O
procedure	procedure	NN	I-NP	O
with	with	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	B-protein
including	include	VBG	B-PP	I-protein
ampicillin	ampicillin	NN	B-NP	I-protein
,	,	,	O	O
gentamicin	gentamicin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Flagyl	Flagyl	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
quality	quality	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
quadrant	quadrant	JJ	I-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
as	as	IN	B-PP	O
sharp	sharp	JJ	B-NP	O
and	and	CC	I-NP	O
constant	constant	JJ	I-NP	O
with	with	IN	B-PP	O
nausea	nausea	NN	B-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
vomiting	vomiting	NN	I-NP	O
,	,	,	O	O
fevers	fever	NNS	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
back	back	RB	B-ADVP	O
pain	pain	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
urinary	urinary	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pain	pain	NN	I-NP	O
lasted	last	VBD	B-VP	O
several	several	JJ	B-NP	O
hours	hour	NNS	I-NP	O
postprandially	postprandially	RB	B-ADVP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
radiation	radiation	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
denies	deny	VBZ	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
or	or	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	HYPH	B-NP	B-protein
1	1	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	O
Coronary	Coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
2	2	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Hypertension	Hypertension	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
3	3	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Diabetes	Diabetes	NNP	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Hyperlipidemia	Hyperlipidemia	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
5	5	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
History	History	NN	I-NP	O
of	of	IN	B-PP	O
posterior	posterior	JJ	B-NP	O
thoracic	thoracic	JJ	I-NP	O
abscess	abscess	NN	I-NP	O
,	,	,	O	O
removed	remove	VBN	B-VP	O
in	in	IN	B-PP	O
April	April	NNP	B-NP	O
1995	1995	CD	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
6	6	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
History	History	NN	I-NP	O
of	of	IN	B-PP	O
scrotal	scrotal	JJ	B-NP	O
abscess	abscess	NN	I-NP	O
with	with	IN	B-PP	O
necrotizing	necrotize	VBG	B-VP	O
fasciitis	fasciitis	NN	B-NP	O
in	in	IN	B-PP	O
1992	1992	CD	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Aspirin	Aspirin	NN	I-NP	O
325	325	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.d.	q.d.	FW	I-NP	O
-LRB-	-LRB-	NN	I-NP	B-protein
2	2	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Lisinopril	Lisinopril	NNP	I-NP	I-protein
40	40	CD	I-NP	I-protein
milligrams	milligram	NNS	I-NP	I-protein
q.d.	q.d.	VBN	B-VP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
3	3	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	I-protein
Mevacor	Mevacor	NNP	I-NP	I-protein
40	40	CD	I-NP	I-protein
milligrams	milligram	NNS	I-NP	I-protein
q.d.	q.d.	VBN	B-VP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
4	4	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
Insulin	Insulin	NN	I-NP	I-protein
NPH	NPH	NN	I-NP	I-protein
subcutaneous	subcutaneous	JJ	I-NP	I-protein
50	50	CD	I-NP	I-protein
units	unit	NNS	I-NP	I-protein
q.a.m.	q.a.m.	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
5	5	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	I-protein
Regular	Regular	JJ	I-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
subcutaneous	subcutaneous	JJ	I-NP	O
10	10	CD	I-NP	O
units	unit	NNS	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
6	6	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Nitroglycerin	Nitroglycerin	NN	I-NP	O
sublingual	sublingual	JJ	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
7	7	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Atenolol	Atenolol	NN	I-NP	O
50	50	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
q.d.	q.d.	VBP	B-VP	O
SOCIAL	SOCIAL	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
wife	wife	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
smoked	smoke	VBN	I-VP	O
one	one	CD	B-NP	O
and	and	CC	O	O
one-half	one-half	JJ	B-NP	O
packs	pack	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
for	for	IN	B-PP	O
34	34	CD	B-NP	O
years	year	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
minimal	minimal	JJ	B-NP	O
alcohol	alcohol	NN	I-NP	O
use	use	NN	I-NP	O
and	and	CC	O	O
,	,	,	O	O
in	in	IN	B-PP	O
fact	fact	NN	B-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
drank	drank	VB	I-VP	O
alcohol	alcohol	NN	B-NP	O
since	since	IN	B-PP	O
1984	1984	CD	B-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
family	family	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
:	:	:	O	O
VITAL	VITAL	JJ	B-NP	O
SIGNS	SIGNS	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	O
97.7	97.7	CD	I-NP	O
.	.	.	O	O

Pulse	Pulse	NN	B-NP	O
52	52	CD	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
98/98	98/98	CD	I-NP	O
.	.	.	O	O

Respirations	Respiration	NNS	B-NP	O
18	18	CD	B-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Anicteric	Anicteric	NNP	B-NP	O
.	.	.	O	O

Oropharynx	Oropharynx	NN	B-NP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
bruits	bruit	NNS	I-NP	O
.	.	.	O	O

LUNGS	LUNGS	NNS	B-NP	O
:	:	:	O	O
Lungs	Lung	NNS	B-NP	O
are	be	VBP	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
.	.	.	O	O

CARDIOVASCULAR	CARDIOVASCULAR	NN	B-NP	O
:	:	:	O	O
Cardiac	Cardiac	JJ	B-NP	O
examination	examination	NN	I-NP	O
regular	regular	JJ	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
S1	S1	NN	I-NP	O
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	O	O
rubs	rub	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
gallops	gallop	NNS	B-NP	O
.	.	.	O	O

BACK	BACK	NN	B-NP	O
:	:	:	O	O
Back	Back	RB	B-ADVP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
costovertebral	costovertebral	JJ	I-NP	O
angle	angle	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
spinal	spinal	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Obese	Obese	NN	B-NP	O
with	with	IN	B-PP	O
positive	positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Right	Right	RB	B-NP	O
upper	upper	JJ	I-NP	O
quadrant	quadrant	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
and	and	CC	I-NP	O
guarding	guarding	NN	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
rebound	rebound	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
Murphy	Murphy	NNP	I-NP	O
's	's	POS	B-NP	O
sign	sign	NN	I-NP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
cyanosis	cyanosis	NN	I-NP	O
,	,	,	I-NP	O
clubbing	clubbing	NN	I-NP	O
or	or	CC	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

NEUROLOGICAL	NEUROLOGICAL	NN	B-NP	O
:	:	:	O	O
Examination	Examination	NN	B-NP	O
was	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
142	142	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.1	4.1	CD	I-NP	O
,	,	,	O	O
CO2	CO2	NN	B-NP	O
102	102	CD	I-NP	O
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
30	30	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NNP	B-NP	O
15	15	CD	I-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.0	1.0	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
247	247	CD	I-NP	O
.	.	.	O	O

WBC	WBC	NN	B-NP	O
at	at	IN	B-PP	O
11.2	11.2	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
41.2	41.2	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
258	258	CD	B-NP	O
.	.	.	O	O

ALT	ALT	NN	B-NP	B-protein
122	122	CD	I-NP	I-protein
,	,	,	O	O
AST	AST	NN	B-NP	B-DNA
172	172	CD	I-NP	I-DNA
,	,	,	O	O
alkaline	alkaline	NN	B-NP	O
phosphatase	phosphatase	NN	I-NP	O
211	211	CD	I-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
0.7	0.7	CD	I-NP	O
,	,	,	O	O
direct	direct	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
0.2	0.2	CD	I-NP	O
.	.	.	O	O

Amylase	Amylase	NN	B-NP	B-protein
38	38	CD	I-NP	I-protein
,	,	,	O	O
Albumin	Albumin	NNP	B-NP	O
3.7	3.7	CD	I-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	O
9.2	9.2	CD	I-NP	O
,	,	,	O	O
phosphate	phosphate	NN	B-NP	O
3.0	3.0	CD	I-NP	O
.	.	.	O	O

Urinalysis	Urinalysis	NN	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

DIAGNOSTIC	DIAGNOSTIC	NN	B-NP	O
STUDIES	STUDIES	NNS	I-NP	O
:	:	:	O	O
Electrocardiogram	Electrocardiogram	NN	B-NP	O
normal	normal	JJ	I-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
62	62	CD	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
is	be	VBZ	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
by	by	IN	B-PP	O
system	system	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Gastrointestinal	Gastrointestinal	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Surgical	Surgical	NNP	I-NP	O
Service	Service	NNP	I-NP	O
for	for	IN	B-PP	O
,	,	,	O	O
likely	likely	RB	B-ADVP	O
,	,	,	O	O
cholecystis	cholecystis	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
managed	manage	VBD	B-VP	O
medically	medically	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
n.p.o.	n.p.o.	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
hydrated	hydrate	VBN	B-VP	O
with	with	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
fluids	fluid	NNS	I-NP	O
and	and	CC	O	O
started	start	VBD	B-VP	O
on	on	IN	B-PP	O
triple	triple	JJ	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
including	include	VBG	B-PP	O
ampicillin	ampicillin	NN	B-NP	O
,	,	,	O	O
gentamicin	gentamicin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Flagyl	Flagyl	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
count	count	NN	I-NP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
Surgical	Surgical	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
alkaline	alkaline	JJ	I-NP	B-protein
phosphatase	phosphatase	NN	I-NP	I-protein
and	and	CC	O	O
total	total	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
became	become	VBD	B-VP	O
elevated	elevated	JJ	B-ADJP	O
and	and	CC	O	O
the	the	DT	B-NP	O
Gastroenterology	Gastroenterology	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Service	Service	NNP	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
for	for	IN	B-PP	O
consideration	consideration	NN	B-NP	O
of	of	IN	B-PP	O
ERCP	ERCP	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
then	then	RB	B-ADVP	O
underwent	undergo	VBD	B-VP	O
ERCP	ERCP	NN	B-NP	B-protein
on	on	IN	B-PP	O
March	March	NNP	B-NP	O
,	,	,	O	O
1999	1999	CD	B-NP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
a	a	DT	B-NP	O
distal	distal	JJ	I-NP	O
common	common	JJ	I-NP	O
bile	bile	NN	I-NP	O
duct	duct	NN	I-NP	O
stone	stone	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
attempt	attempt	NN	I-NP	O
at	at	IN	B-PP	O
removal	removal	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
stone	stone	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
stone	stone	NN	I-NP	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
extracted	extract	VBN	I-VP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
was	be	VBD	B-VP	O
aborted	abort	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Medical	Medical	NNP	I-NP	O
Service	Service	NNP	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
liver	liver	NN	I-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
after	after	IN	B-SBAR	O
the	the	DT	B-NP	O
attempt	attempt	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
common	common	JJ	I-NP	O
bile	bile	NN	I-NP	O
duct	duct	NN	I-NP	O
stone	stone	NN	I-NP	O
removal	removal	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
remain	remain	VB	I-VP	O
pain	pain	NN	B-NP	O
free	free	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
afebrile	afebrile	JJ	I-ADJP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
the	the	DT	B-NP	O
observation	observation	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
common	common	JJ	I-NP	O
bile	bile	NN	I-NP	O
duct	duct	NN	I-NP	O
stone	stone	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
GI	GI	NNP	I-NP	O
Service	Service	NNP	I-NP	O
thought	think	VBD	B-VP	O
it	it	PRP	B-NP	O
appropriate	appropriate	JJ	B-ADJP	O
to	to	TO	B-VP	O
take	take	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
back	back	RB	B-ADVP	O
for	for	IN	B-PP	O
repeat	repeat	NN	B-NP	O
ERCP	ERCP	NN	I-NP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
later	later	RB	B-ADVP	O
.	.	.	O	O

Repeat	Repeat	NN	B-NP	O
ERCP	ERCP	NN	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
residual	residual	JJ	I-NP	O
stone	stone	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
additional	additional	JJ	I-NP	O
stones	stone	NNS	I-NP	O
were	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
advanced	advance	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
tolerated	tolerate	VBD	B-VP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Surgical	Surgical	NNP	I-NP	O
Service	Service	NNP	I-NP	O
who	who	WP	B-NP	O
recommended	recommend	VBD	B-VP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
,	,	,	O	O
an	an	DT	B-NP	O
elective	elective	JJ	I-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
later	later	JJ	I-NP	O
date	date	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
2	2	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Cardiovascular	Cardiovascular	NNP	I-NP	O
:	:	:	O	O
Given	Give	VBN	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
cardiology	cardiology	NN	I-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Surgical	Surgical	NNP	I-NP	O
Service	Service	NNP	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
then	then	RB	B-ADVP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
once	once	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Medical	Medical	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

Preoperative	Preoperative	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
included	include	VBD	B-VP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
history	history	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
coronary	coronary	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
in	in	IN	B-PP	O
1995	1995	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
30	30	CD	I-NP	O
percent	percent	NN	I-NP	O
left	leave	VBD	B-VP	O
anterior	anterior	RB	I-VP	O
descending	descend	VBG	I-VP	O
artery	artery	NN	B-NP	O
,	,	,	O	O
proximal	proximal	JJ	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
mid	mid	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-NP	O
well	well	RB	I-NP	O
clean	clean	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
,	,	,	O	O
70	70	CD	B-NP	O
to	to	TO	I-NP	O
90	90	CD	I-NP	O
percent	percent	NN	I-NP	O
obtuse	obtuse	NN	I-NP	O
marginal	marginal	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
40	40	CD	I-NP	O
percent	percent	NN	I-NP	O
,	,	,	O	O
40	40	CD	B-NP	O
percent	percent	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
70	70	CD	B-NP	O
percent	percent	NN	I-NP	O
serial	serial	JJ	I-NP	O
right	right	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
lesions	lesion	NNS	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
70	70	CD	I-NP	O
percent	percent	NN	I-NP	O
posterior	posterior	JJ	I-NP	O
descending	descend	VBG	I-NP	O
artery	artery	NN	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
obtuse	obtuse	VBP	B-VP	O
marginal	marginal	JJ	B-NP	O
angioplasty	angioplasty	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
.	.	.	O	O

An	An	DT	B-NP	O
left	left	JJ	I-NP	O
ventriculogram	ventriculogram	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
69	69	CD	B-NP	O
percent	percent	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
January	January	NNP	B-NP	O
1996	1996	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
test	test	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
went	go	VBD	B-VP	O
six	six	CD	B-NP	O
minutes	minute	NNS	I-NP	O
and	and	CC	O	O
30	30	CD	B-NP	O
seconds	second	NNS	I-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
millimeter	millimeter	NN	I-NP	O
ST	ST	NN	I-NP	O
depressions	depression	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
highly	highly	RB	B-ADJP	O
predictive	predictive	JJ	I-ADJP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
symptoms	symptom	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
refused	refuse	VBD	B-VP	O
intervention	intervention	NN	B-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
cardiology	cardiology	NN	I-NP	O
consult	consult	NN	I-NP	O
concluded	conclude	VBD	B-VP	O
that	that	IN	B-SBAR	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
recommendation	recommendation	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
to	to	TO	B-VP	O
perform	perform	VB	I-VP	O
a	a	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	O
imaging	imaging	NN	I-NP	O
study	study	NN	I-NP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
ischemic	ischemic	JJ	I-NP	O
risk	risk	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
test	test	NN	I-NP	O
MIBI	MIBI	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
,	,	,	O	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
good	good	JJ	I-NP	O
work	work	NN	I-NP	O
load	load	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
moderate	moderate	JJ	B-ADJP	O
to	to	TO	B-PP	O
severe	severe	JJ	B-NP	O
inferoapical	inferoapical	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
on	on	IN	B-PP	O
MIBI	MIBI	NNP	B-NP	O
images	image	NNS	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
the	the	DT	B-NP	O
urgent	urgent	JJ	I-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
ERCP	ERCP	NN	B-NP	B-protein
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
,	,	,	O	O
catheterization	catheterization	NN	B-NP	O
was	be	VBD	B-VP	O
postponed	postpone	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
free	free	JJ	B-ADJP	O
and	and	CC	O	O
symptom	symptom	NN	B-NP	O
free	free	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
cardiology	cardiology	NN	I-NP	O
perspective	perspective	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
medications	medication	NNS	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
included	include	VBD	B-VP	O
Lopressor	Lopressor	NN	B-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Diltiazem	Diltiazem	NNP	B-NP	O
.	.	.	O	O

Persistent	Persistent	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
was	be	VBD	B-VP	O
controlled	control	VBN	I-VP	O
by	by	IN	B-PP	O
increasing	increase	VBG	B-VP	O
the	the	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
beta	beta	SYM	B-NP	O
blocker	blocker	NN	I-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
consideration	consideration	NN	B-NP	O
of	of	IN	B-PP	O
ERCP	ERCP	NN	B-NP	B-protein
and	and	CC	O	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
gastrointestinal	gastrointestinal	JJ	B-NP	O
bleed	bleed	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
symptom	symptom	NN	B-NP	O
free	free	JJ	B-ADJP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
standpoint	standpoint	NN	I-NP	O
,	,	,	O	O
cardiology	cardiology	NN	B-NP	O
consult	consult	NN	I-NP	O
decided	decide	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
deferred	defer	VBN	I-VP	O
until	until	IN	B-PP	O
after	after	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
light	light	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
possible	possible	JJ	I-NP	O
complications	complication	NNS	I-NP	O
of	of	IN	B-PP	O
adding	add	VBG	B-VP	O
a	a	DT	B-NP	O
TB3A	TB3A	NN	I-NP	O
antagonist	antagonist	NN	I-NP	O
during	during	IN	B-PP	O
percutaneous	percutaneous	JJ	B-NP	O
transluminal	transluminal	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
angioplasty	angioplasty	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
context	context	NN	I-NP	O
of	of	IN	B-PP	O
possible	possible	JJ	B-NP	O
ERCP	ERCP	NN	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
up	up	RP	B-PRT	O
in	in	IN	B-PP	O
cardiology	cardiology	NN	B-NP	O
for	for	IN	B-PP	O
elective	elective	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
3	3	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Endocrine	Endocrine	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
diabetes	diabetes	NN	I-NP	O
was	be	VBD	B-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
insulin	insulin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
while	while	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
n.p.o.	n.p.o.	NN	B-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
insulin	insulin	NN	I-NP	B-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
4	4	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Infectious	Infectious	JJ	I-NP	O
disease	disease	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
ampicillin	ampicillin	NN	B-NP	O
,	,	,	O	O
gentamicin	gentamicin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Flagly	Flagly	RB	B-ADVP	O
per	per	IN	B-PP	O
surgery	surgery	NN	B-NP	O
recommendations	recommendation	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	SYM	B-NP	B-protein
1	1	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
Aspirin	Aspirin	NN	I-NP	I-protein
325	325	CD	B-NP	I-protein
milligrams	milligram	NNS	I-NP	I-protein
p.o.	p.o.	FW	B-NP	I-protein
q.d.	q.d.	FW	I-NP	I-protein
-LRB-	-LRB-	SYM	I-NP	I-protein
2	2	CD	I-NP	I-protein
-RRB-	-RRB-	SYM	I-NP	I-protein
NPH	NPH	NN	I-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
subcutaneous	subcutaneous	JJ	I-NP	I-protein
50	50	CD	I-NP	I-protein
units	unit	NNS	I-NP	I-protein
q.a.m.	q.a.m.	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
3	3	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	I-protein
Regular	Regular	JJ	I-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
subcutaneous	subcutaneous	JJ	I-NP	I-protein
10	10	CD	I-NP	I-protein
units	unit	NNS	I-NP	I-protein
q.a.m.	q.a.m.	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	O	I-protein
4	4	CD	B-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
Lisinopril	Lisinopril	NNP	B-NP	O
40	40	CD	I-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	FW	I-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
5	5	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Nitroglycerin	Nitroglycerin	NN	I-NP	O
1	1	CD	I-NP	O
tablet	tablet	NN	I-NP	O
sublingual	sublingual	JJ	I-NP	O
q.	q.	NN	I-NP	O
5	5	CD	B-NP	O
minutes	minute	NNS	I-NP	O
times	time	NNS	I-NP	O
three	three	CD	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
6	6	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Procardia	Procardia	NNP	I-NP	O
XL	XL	NNP	I-NP	O
90	90	CD	I-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.d.	q.d.	FW	I-NP	O
-LRB-	-LRB-	SYM	I-NP	O
7	7	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Atenolol	Atenolol	NN	I-NP	O
50	50	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.d.	q.d.	FW	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
ADA	ADA	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
,	,	,	O	O
000	000	CD	B-NP	O
calories	calorie	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
saturated	saturate	VBN	I-NP	O
fat	fat	NN	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

FOLLOW	FOLLOW	JJ	B-NP	O
UP	UP	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
surgery	surgery	NN	I-NP	O
clinic	clinic	NN	I-NP	O
for	for	IN	B-PP	O
scheduling	scheduling	NN	B-NP	O
of	of	IN	B-PP	O
elective	elective	JJ	B-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
on	on	IN	B-PP	O
October	October	NNP	B-NP	O
,	,	,	O	O
1999	1999	CD	B-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
cardiology	cardiology	NN	B-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
elective	elective	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
SOLOMON	SOLOMON	NNP	B-NP	O
WANKE	WANKE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
ALONSO	ALONSO	NN	B-NP	O
MCALEVY	MCALEVY	NN	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
QX97	QX97	NNP	I-NP	O
AV364/9528	AV364/9528	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
16832	16832	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

FTVNIX63PM	FTVNIX63PM	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
10/12/99	10/12/99	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
5/10/99	5/10/99	CD	B-NP	O

